Issuers, get 33% more new shareholders with investorHub. Learn more
Learn
Looking for more information?
Contact our responsive and friendly client services team any time.
Current price
$0.18
▾0.01 (5.88%)
Last trade: 08/06, 12:46PM
Market cap
$41.05m
Market closed
Talk to Kazia Therapeutics Limited directly.
Sign up to their Investor Hub for direct access to the Kazia Therapeutics Limited team, ask them questions, and see personal updates.
Investor Presentations
Principal Activity
Kazia Therapeutics Limited Is an oncology-focused biotechnology company. KZA is focused on the development of novel anti-cancer drugs based on two proprietary drug technologies known as Super-benzopyrans and Anti-tropomyosins. KZA is headquartered in Sydney, Australia, with an office in New Haven, Connecticut in the US.
Address
f24/300 Barangaroo Avenue, Sydney NSW 2000, Australia
Website
News
Announcements
Filter
| Announcement | T+2 Movement | Date |
|---|---|---|
Market Data
Day
3m
1yr
5yr
Current price
$0.18
Open price
-
Day low-high
-
Price change
Percent change
Previous close
-
Volume
-
Turnover
-
Bid price
-
Ask price
-
Market cap
-
Shares outstanding
-
Year high
-
Year low
-
Year low-high
-
Earnings per share
-
Price/earnings ratio
-
Dividend yield
-
Dividend per share
-
Franking
-
Investor Presentations
News
Sector Peers
| Company | Market Cap | ||
|---|---|---|---|
Support
Live Chat
Markets
Contact Us
(03) 9661 0441
clients@freshequities.com
Address
Level 16, 452 Flinders St
Melbourne VIC 3000
Australia